基于前海人寿举牌万科的视角浅析我国保险资金股票投资的监管

Analysis of Chinese Insurance Stock Investment Supervision from the Perspective of Foresea Life Insurance Holding Vanke

随着宝能系对万科股票的持续减持,始于2015年并在我国金融市场留下浓墨重彩的"宝万之争"终于画上了句号。这场"闹剧"实际上暴露了我国当时监管机构对保险公司股票投资监管的短板。最近几年,监管机构持续完善保险公司资金运用方面的监管制度,2018年《保险公司资金运用管理办法》出台,我国险资运用监管进入了新的时期。本文从前海人寿举牌万科的案例出发,讨论"闹剧"的成因以及由此暴露的我国保险资金股票投资监管制度的不足,浅析事件发生之后我国在险资股票投资监管方面获得的进步,最后列举若干针对我国现行险资股票投资监管制度的完善建议提供参考。

Along with the continuous reduction of Vanke stock held by Baoneng Department,the"Competition between Baoneng and Vanke"that began in 2015 and kept a strong presence in Chinese financial market finally came to an end.It exposed the shortcomings of Chinese regulatory agencies in the supervision of insurance company stock investment.In recent years,the supervision system has continued to improve the supervision system for the use of funds of insurance companies.With the introduction of the Measures for the Management of Fund Use of Insurance Companies in 2018,the supervision of the use of insurance funds in China has entered a new period.This article will start from the case of Foresea Life Insurance’s placard of Vanke,discuss the cause of the"farce"and the insufficiency of the supervision system of Chinese insurance fund stock investment exposed thereby,and then this article will analyze the gains in insurance fund stock investment supervision after the incident.At the end,it enumerates several suggestions for perfecting the supervision system of current insurance capital stock investment.